FDA Approved: BELEODAQ — Supplemental Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approved a supplemental application for Beleodaq (belinostat) submitted by Acrotech Biopharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• BELEODAQ (BELINOSTAT)

Snippet

SUPPL AP for BELEODAQ (BELINOSTAT)